Equities
Health CareMedical Equipment and Services
  • Price (SEK)89.70
  • Today's Change3.75 / 4.36%
  • Shares traded423.74k
  • 1 Year change-56.33%
  • Beta2.3102
Data delayed at least 15 minutes, as of Feb 13 2026 17:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Key statistics

Vitrolife AB (VITR:STO) set a new 52-week low during Thursday's trading session when it reached 84.90. Over this period, the share price is down -56.54%.
52-week range
Today
84.90Feb 12 2026230.60Feb 19 2025
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open86.00
High90.35
Low85.45
Bid89.70
Offer89.70
Previous close85.95
Average volume723.89k
Shares outstanding135.45m
Free float75.02m
P/E (TTM)--
Market cap11.64bn SEK
EPS (TTM)-37.01
SEK
Annual div (ADY)1.10
SEK
Annual div yield (ADY)1.28%
Div ex-dateApr 30 2025
Div pay-dateMay 07 2025
Next div ex-dateMay 06 2026
Next div pay-dateMay 12 2026
Data delayed at least 15 minutes, as of Feb 13 2026 17:00 GMT.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.